The Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study was conducted in Benin, Nigeria, and Uganda. The study aims to assess patients’/caregivers’ preference for a paediatric DTG regimen over their previous regimen, when transitioned from another regimen.
Click here to see a slide deck walking through initial results from August 2022, and here to see the updated results as of February 2023.
